1
|
Lombardi G, Di Russo M, Zjalic D, Lanza T, Simmons M, Moscato U, Ricciardi W, Chiara C. Microplastics inhalation and their effects on human health: a systematic review. Eur J Public Health 2022. [DOI: 10.1093/eurpub/ckac131.152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Microplastics (MPs) are defined as small particles less than 5 mm in size occuring in the environment as a consequence of plastic pollution. MPs are classified into primary MPs, which are created for industrial uses, and secondary MPs, that derive from the degradation of larger plastic items. With the global increase in plastic production, MPs have become widely distributed in the natural ecosystems and have been charged with causing several detrimental effects on both the environment and on human health. Moreover, plastics often include additives to improve their properties, which may produce additional toxic substances. Humans can be exposed to MPs through different pathways, including ingestion, inhalation and dermal contact. The aim of this systematic review is to synthesize whether inhaled microplastics and plastic additives have negative effects on human health.
Methods
MEDLINE, Scopus and Web of Science were searched starting from December 2021. The systematic review was conducted according to the PRISMA guidelines. Eligible studies were primary studies which reported the effects of inhaled MPs on the respiratory system. Appropriate quality assessment tools were used according to the study design of primary studies.
Results
38 studies met the inclusion criteria. Most of the studies were conducted in vitro, while there was a scarcity of papers that investigated the effects of MPs in population cohorts. Preliminary results show that MPs can induce pro-inflammatory or pro-carcinogenic effects by different mechanisms, depending on particles’ concentration, size, type and surface charge.
Conclusions
Literature has underlined several negative health concerns resulting from the absorption of microplastics and plastic additives. By gathering this information, this systematic review sheds light on the possible threats of MPs inhalation to human health and discusses whether an implementation of new public health policies for the foreseeable future is needed.
Key messages
• Inhalation is a major route of exposure to microplastics.
• Inhaled microplastics or plastic additives may have detrimental effects on human health, promoting respiratory diseases or carcinogenic processes.
Collapse
Affiliation(s)
- G Lombardi
- Department of Life Sciences and Public Health, Catholic University of Sacred Heart , Rome, Italy
- Istituto di Planetary Health , Rome, Italy
| | - M Di Russo
- Department of Life Sciences and Public Health, Catholic University of Sacred Heart , Rome, Italy
- Istituto di Planetary Health , Rome, Italy
| | - D Zjalic
- Department of Life Sciences and Public Health, Catholic University of Sacred Heart , Rome, Italy
- Istituto di Planetary Health , Rome, Italy
| | - T Lanza
- Department of Life Sciences and Public Health, Catholic University of Sacred Heart , Rome, Italy
- Istituto di Planetary Health , Rome, Italy
| | - M Simmons
- College of Population Health, Thomas Jefferson University , Philadelphia, USA
| | - U Moscato
- Department of Life Sciences and Public Health, Catholic University of Sacred Heart , Rome, Italy
| | - W Ricciardi
- Department of Life Sciences and Public Health, Catholic University of Sacred Heart , Rome, Italy
- Istituto di Planetary Health , Rome, Italy
| | - C Chiara
- Department of Life Sciences and Public Health, Catholic University of Sacred Heart , Rome, Italy
- Istituto di Planetary Health , Rome, Italy
| |
Collapse
|
2
|
Miano M, Grossi A, Dell'Orso G, Lanciotti M, Fioredda F, Palmisani E, Lanza T, Guardo D, Beccaria A, Ravera S, Cossu V, Terranova P, Giona F, Santopietro M, Cappelli E, Ceccherini I, Dufour C. Genetic screening of children with marrow failure. The role of primary Immunodeficiencies. Am J Hematol 2021; 96:1077-1086. [PMID: 34000087 DOI: 10.1002/ajh.26242] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2021] [Revised: 05/12/2021] [Accepted: 05/12/2021] [Indexed: 12/16/2022]
Abstract
The differential diagnosis of marrow failure (MF) is crucial in the diagnostic work-up, since genetic forms require specific care. We retrospectively studied all patients with single/multi-lineage MF evaluated in a single-center to identify the type and incidence of underlying molecular defects. The diepoxybutane test was used to screen Fanconi Anemia. Other congenital MFs have been searched using Sanger and/or Next Generation Sequencing analysis, depending on the available tools over the years. Between 2009-2019, 97 patients (aged 0-32 years-median 5) with single-lineage (29%) or multilineage (68%) MF were evaluated. Fifty-three (54%) and 28 (29%) were diagnosed with acquired and congenital MF, respectively. The remaining 16 (17%), with trilinear (n=9) and monolinear (n=7) MF, were found to have an underlying primary immunodeficiency (PID) and showed clinical and biochemical signs of immune-dysregulation in 10/16 (62%) and in 14/16 (87%) of cases, respectively. Clinical signs were also found in 22/53 (41%) and 8/28 (28%) patients with idiopathic and classical cMF, respectively. Eight out of 16 PIDs patients were successfully transplanted, four received immunosuppression, two did not require treatment, and the remaining two died. We show that patients with single/multi-lineage MF may have underlying PIDs in a considerable number of cases and that MF may represent a relevant clinical sign in patients with PIDs, thus widening their clinical phenotype. An accurate immunological work-up should be performed in all patients with MF, and PID-related genes should be considered when screening MF in order to identify disorders that may receive targeted treatments and/or appropriate conditioning regimens before transplant.
Collapse
Affiliation(s)
- Maurizio Miano
- Hematology Unit IRCCS Istituto Giannina Gaslini Genoa Italy
| | - Alice Grossi
- UOSD Genetics and Genomics of Rare Diseases IRCCS Istituto Giannina Gaslini Genoa Italy
| | | | | | | | | | - Tiziana Lanza
- Hematology Unit IRCCS Istituto Giannina Gaslini Genoa Italy
| | - Daniela Guardo
- Hematology Unit IRCCS Istituto Giannina Gaslini Genoa Italy
| | | | - Silvia Ravera
- Department of Experimental Medicine University of Genoa Genoa Italy
| | - Vanessa Cossu
- Department of Health Sciences University of Genoa Genoa Italy
| | | | - Fiorina Giona
- Department of Translational and Precision Medicine Sapienza University Rome Italy
| | - Michelina Santopietro
- Hematology and Hematopoietic Stem Cells Transplant Unit AO San Camillo‐Forlanini Rome Italy
| | | | - Isabella Ceccherini
- UOSD Genetics and Genomics of Rare Diseases IRCCS Istituto Giannina Gaslini Genoa Italy
| | - Carlo Dufour
- Hematology Unit IRCCS Istituto Giannina Gaslini Genoa Italy
| |
Collapse
|
3
|
Maggiore R, Grossi A, Fioredda F, Palmisani E, Terranova P, Cappelli E, Lanza T, Pierri F, Guardo D, Calvillo M, Micalizzi C, Beccaria A, Coccia MC, Arrigo S, Dufour C, Ceccherini I, Miano M. Unusual Late-onset Enteropathy in a Patient With Lipopolysaccharide-responsive Beige-like Anchor Protein Deficiency. J Pediatr Hematol Oncol 2020; 42:e768-e771. [PMID: 31876783 DOI: 10.1097/mph.0000000000001708] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
In recent years, monogenic causes of immune dysregulation syndromes, with variable phenotypes, have been documented. Mutations in the lipopolysaccharide-responsive beige-like anchor (LRBA) protein are associated with common variable immunodeficiency, autoimmunity, chronic enteropathy, and immune dysregulation disorders. The LRBA protein prevents degradation of cytotoxic T-lymphocyte antigen 4 (CTLA4) protein, thus inhibiting immune responses. Both LRBA and CTLA4 deficiencies usually present with immune dysregulation, mostly characterized by autoimmunity and lymphoproliferation. In this report, we describe a patient with an atypical clinical onset of LRBA deficiency and the patient's response to abatacept, a fusion protein-drug that mimics the action of CTLA4.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | - Serena Arrigo
- Gastroenterology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy
| | | | | | | |
Collapse
|
4
|
Lanza T, Carini E, Villani L, Ricciardi W, Moscato U. Air pollution health risk assessment: the role of benzene. Eur J Public Health 2020. [DOI: 10.1093/eurpub/ckaa166.087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Benzene is an aromatic polycyclic hydrocarbon (C6H6) ubiquitously present in the environment which results from the emissions of fires and volcanoes. However, the primary source is anthropogenic, mainly from industrial emissions and combustion. The aim of this study is to summarize the current evidence on benzene exposure in the Italian regions and the main health effects.
A retrospective observational study was conducted. Environmental data provided by ISPRA (Higher Institute for Environmental Protection and Research) relating to benzene pollution and the trend of national emissions of substance by region and sector of origin were analyzed.
Data available to date (1990-2016) show a significant decrease, over 91%, mainly due to the reduction in the transport sector. In 2016, the main share of substance relates to road transport (1,492 t), followed by use of solvents (1,100 t), and production processes (463 t). Much lower are the emissions due to the extraction and distribution of fossil fuels/geothermal (19 t) and combustion in the energy and transformation industries (5 t). The highest absolute values in 2015 were recorded in the Italian regions of Lombardia (751.4 t), Lazio (367.2 t), and Puglia (339.0 t). The lower values were in Valle d'Aosta (7.9 t), Molise (15,5 t) and Basilicata (25,3 t). The largest decrease in benzene exposure between 1990 and 2015 was recorded in Campania (-94.5%), Calabria (-93.9%) and Valle d'Aosta (-93.4%).
All Italian regions recorded a significant decrease in the absolute values of benzene emissions, mainly due to both the decrease of benzene in fuel composition during the 1990s and to the renewal of circulating cars equipped with energy saving systems (start and stop) and more optimized for low fuel consumption. The global reduction of energy sources based on fossil fuels, as well as a primary environmental objective to reduce Global Warming, would certainly constitute a way to decrease the impact of benzene on the environment.
Key messages
Additional efforts are needed to reduce energy sources based on fossil fuels. An information, training and health education policy through the environment aimed at implementing awareness and empowerment of the population would be desirable.
Collapse
Affiliation(s)
- T Lanza
- Università Cattolica del Sacro Cuore, Rome, Italy
| | - E Carini
- Università Cattolica del Sacro Cuore, Rome, Italy
| | - L Villani
- Università Cattolica del Sacro Cuore, Rome, Italy
| | - W Ricciardi
- Università Cattolica del Sacro Cuore, Rome, Italy
- Fondazione Policlinico, Rome, Italy
| | - U Moscato
- Università Cattolica del Sacro Cuore, Rome, Italy
- Fondazione Policlinico, Rome, Italy
| |
Collapse
|
5
|
Miano M, Madeo A, Cappelli E, Lanza F, Lanza T, Stroppiano M, Terranova P, Venè R, Bleesing JJH, Di Rocco M. Defective FAS-Mediated Apoptosis and Immune Dysregulation in Gaucher Disease. J Allergy Clin Immunol Pract 2020; 8:3535-3542. [PMID: 32702516 DOI: 10.1016/j.jaip.2020.06.065] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/05/2020] [Revised: 06/29/2020] [Accepted: 06/30/2020] [Indexed: 11/26/2022]
Abstract
BACKGROUND Gaucher disease (GD) is a rare disorder characterized by defective function of β-glucocerebrosidase, which leads to progressive accumulation of its substrate in various organs, particularly the mononuclear phagocyte system. Hepatosplenomegaly and cytopenia represent the disease's most common features, but patients with GD also show hyperinflammation, hypergammaglobulinemia, and immune dysregulation involving B, T, and natural killer cells. As clinical phenotype can be underhand, symptoms can overlap with autoimmune lymphoproliferative syndrome (ALPS) or other ALPS-like disorders. OBJECTIVE To evaluate the ALPS-like immunological pattern and apoptosis function in patients with GD. METHODS We evaluated lymphocyte subsets and immunophenotypic and serological features of ALPS (double-negative T cells [DNTs], B220+DNTs, CD27+, T-reg/HLA-DR ratio, IL-10, IL-18, vitamin B12) in a population of patients with GD. Moreover, we tested FAS/TRAIL-induced apoptosis and CASP8/CASP10/PARP function in patients showing an immune-dysregulation pattern. RESULTS A total of 41 patients (33 treated, 8 treatment-naïve) were studied. Nine (21%) and 7 (17%) of 41 patients had high DNT and B220+DNT counts, respectively. Overall, 10 of 41(24%) patients showed immunological features suggestive of ALPS that were more frequent in treatment-naïve subjects (P = .040 vs P = .031) and in those with early onset of the disease (P = .046 vs P = .011), respectively. FAS-induced apoptosis and caspase activation were further evaluated in these 10 patients and were found to be defective in 7 of them. CONCLUSIONS We show that patients with GD may have ALPS-like features and FAS-mediated apoptosis defects that are more pronounced in treatment-naïve subjects and in patients with early onset of the disease. Therefore, diagnostic workup of patients with an ALPS-like phenotype should include screening for GD.
Collapse
Affiliation(s)
- Maurizio Miano
- Hematology Unit, Department of Hematology and Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Giannina Gaslini, Genoa, Italy
| | - Annalisa Madeo
- Unit of Rare Diseases, Department of Pediatrics, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Giannina Gaslini, Genoa, Italy
| | - Enrico Cappelli
- Hematology Unit, Department of Hematology and Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Giannina Gaslini, Genoa, Italy
| | - Federica Lanza
- Laboratory of Molecular Genetics and Biobanks, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Giannina Gaslini, Genoa, Italy
| | - Tiziana Lanza
- Hematology Unit, Department of Hematology and Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Giannina Gaslini, Genoa, Italy
| | - Marina Stroppiano
- Laboratory of Molecular Genetics and Biobanks, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Giannina Gaslini, Genoa, Italy
| | - Paola Terranova
- Hematology Unit, Department of Hematology and Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Giannina Gaslini, Genoa, Italy
| | - Roberta Venè
- Molecular Oncology and Angiogenesis Unit, Istituto di Ricovero e Cura a Carattere Scientifico, San Martino-IST, Genoa, Italy
| | - Jack J H Bleesing
- Division of Bone Marrow Transplantation and Immune Deficiencies, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
| | - Maja Di Rocco
- Unit of Rare Diseases, Department of Pediatrics, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Giannina Gaslini, Genoa, Italy.
| |
Collapse
|
6
|
Miano M, Cappelli E, Pezzulla A, Venè R, Grossi A, Terranova P, Palmisani E, Maggiore R, Guardo D, Lanza T, Calvillo M, Micalizzi C, Pierri F, Vernarecci C, Beccaria A, Corsolini F, Lanciotti M, Russo G, Ceccherini I, Dufour C, Fioredda F. FAS‐mediated apoptosis impairment in patients with ALPS/ALPS‐like phenotype carrying variants on
CASP10
gene. Br J Haematol 2019; 187:502-508. [DOI: 10.1111/bjh.16098] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2019] [Accepted: 05/21/2019] [Indexed: 02/05/2023]
Affiliation(s)
- Maurizio Miano
- Haematology Unit IRCCS Istituto Giannina Gaslini GenoaItaly
| | | | - Agnese Pezzulla
- Haematology Unit IRCCS Istituto Giannina Gaslini GenoaItaly
- Pediatric Hematology/Oncology Unit University of Catania CataniaItaly
| | - Roberta Venè
- Molecular Oncology and Angiogenesis Unit IRCCS Ospedale Policlinico San Martino GenoaItaly
| | - Alice Grossi
- Genetic Unit IRCCS Istituto Giannina Gaslini GenoaItaly
| | | | | | | | - Daniela Guardo
- Haematology Unit IRCCS Istituto Giannina Gaslini GenoaItaly
- Haematology Clinic, Department of Internal Medicine (DiMI) University of Genoa, IRCCS AOU S. Martino‐IST GenoaItaly
| | - Tiziana Lanza
- Haematology Unit IRCCS Istituto Giannina Gaslini GenoaItaly
| | | | | | | | | | | | - Fabio Corsolini
- Laboratory of Molecular Genetics and Biobanks IRCCS Istituto Giannina Gaslini Genoa Italy
| | | | - Giovanna Russo
- Pediatric Hematology/Oncology Unit University of Catania CataniaItaly
| | | | - Carlo Dufour
- Haematology Unit IRCCS Istituto Giannina Gaslini GenoaItaly
| | | |
Collapse
|
7
|
Farruggia P, Fioredda F, Puccio G, Onofrillo D, Russo G, Barone A, Bonanomi S, Boscarol G, Finocchi A, Ghilardi R, Giordano P, Ladogana S, Lassandro G, Luti L, Lanza T, Mandaglio R, Marra N, Martire B, Mastrodicasa E, Motta M, Notarangelo LD, Pillon M, Porretti L, Serafinelli J, Trizzino A, Tucci F, Veltroni M, Verzegnassi F, Ramenghi U, Dufour C. Idiopathic neutropenia of infancy: Data from the Italian Neutropenia Registry. Am J Hematol 2019; 94:216-222. [PMID: 30456824 DOI: 10.1002/ajh.25353] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2018] [Revised: 10/27/2018] [Accepted: 11/12/2018] [Indexed: 01/13/2023]
Abstract
Autoimmune neutropenia of infancy (AIN) is characterized by low risk of severe infection, tendency to spontaneously resolve and typically onset at ≤4-5 years of age; it is due to auto-antibodies whose detection is often difficult. In case of negativity of 4 antineutrophils autoantibody tests, after having excluded ethnic, postinfection, drug induced, or congenital neutropenia, according to the Italian guidelines the patients will be defined as affected by "idiopathic neutropenia" (IN). We describe the characteristics of 85 IN patients enrolled in the Italian neutropenia registry: they were compared with 336 children affected by AIN. The 2 groups were clinically very similar and the main differences were detection age (later in IN), length of disease (longer in IN) and, among recovered patients, age of spontaneous recovery: the median age at resolution was 2.13 years in AINs and 3.03 years in INs (P = .00002). At bivariate analysis among AIN patients earlier detection age (P = .00013), male sex (P = .000748), absence of leucopenia (P = .0045), and absence of monocytosis (P = .0419) were significantly associated with earlier recovery; in the IN group only detection age (P = .013) and absence of monocytosis (P = .0333) were significant. At multivariate analysis detection age and absence of monocytosis were independently significant (P = 6.7e-05 and 4.4e-03, respectively) in the AIN group, whereas in the IN group only detection age stayed significant (P = .013).
Collapse
Affiliation(s)
- Piero Farruggia
- Pediatric Hematology and Oncology Unit; A.R.N.A.S. Ospedale Civico; Palermo Italy
| | - Francesca Fioredda
- Clinical and Experimental Unit G. Gaslini Children's Hospital; Genoa Italy
| | - Giuseppe Puccio
- Department of Sciences for Health Promotion; University of Palermo; Palermo Italy
| | - Daniela Onofrillo
- Pediatric Hematology and Oncology Unit, Department of Hematology; Spirito Santo Hospital; Pescara Italy
| | - Giovanna Russo
- Pediatric Hematology and Oncology Unit, Azienda Policlinico-Vittorio Emanuele; University of Catania; Catania Italy
| | - Angelica Barone
- Department of Pediatric Onco-Hematology; University Hospital; Parma Italy
| | - Sonia Bonanomi
- MBBM Foundation, Department of Pediatrics; University of Milano - Bicocca; Monza Italy
| | - Gianluca Boscarol
- Department of Pediatrics; Central Teaching Hospital Bolzano; Bolzano Italy
| | | | - Roberta Ghilardi
- Department of Pediatrics; Ospedale Maggiore Policlinico IRCCS; Milan Italy
| | - Paola Giordano
- Department of Biomedical Sciences and Human Oncology; Pediatric Section, University "A. Moro" of Bari; Bari Italy
| | - Saverio Ladogana
- Department of Hematology; IRCCS Casa Sollievo della Sofferenza; San Giovanni Rotondo Italy
| | - Giuseppe Lassandro
- Department of Biomedical Sciences and Human Oncology; Pediatric Section, University "A. Moro" of Bari; Bari Italy
| | - Laura Luti
- Pediatric Hematology Oncology; Bone Marrow Transplant, Azienda Ospedaliero Universitaria Pisana, S. Chiara Hospital; Pisa Italy
| | - Tiziana Lanza
- Clinical and Experimental Unit G. Gaslini Children's Hospital; Genoa Italy
| | | | | | - Baldassare Martire
- Pediatric Science and Surgery Department; Pediatric Onco-Hematology Unit, Hospital Policlinico- Giovanni XXIII; Bari Italy
| | - Elena Mastrodicasa
- Pediatric Oncology Hematology Unit; S. Maria Della Misericordia Hospital; Perugia Italy
| | - Milena Motta
- Pediatric Hematology and Oncology Unit, Azienda Policlinico-Vittorio Emanuele; University of Catania; Catania Italy
| | - Lucia Dora Notarangelo
- Onco-Haematology and Bone Marrow Transplantation Unit; Children's Hospital; Brescia Italy
| | - Marta Pillon
- Pediatric Onco-Hematology Department; University of Padova; Padova
| | - Laura Porretti
- Flow Cytometry Service; Laboratory of Clinical Chemistry and Microbiology, IRCCS “Ca‘ Granda” Foundation, Maggiore Hospital Policlinico; Milan Italy
| | | | - Angela Trizzino
- Pediatric Hematology and Oncology Unit; A.R.N.A.S. Ospedale Civico; Palermo Italy
| | - Fabio Tucci
- Department of Pediatric Onco-Hematology; Meyer Children's Hospital; Florence Italy
| | - Marinella Veltroni
- Department of Pediatric Onco-Hematology; Meyer Children's Hospital; Florence Italy
| | - Federico Verzegnassi
- Institute for Maternal and Child Health (I.R.C.C.S) Burlo Garofolo; Trieste Italy
| | - Ugo Ramenghi
- Department of Pediatric and Public Health Sciences; University of Torino; Italy
| | - Carlo Dufour
- Clinical and Experimental Unit G. Gaslini Children's Hospital; Genoa Italy
| |
Collapse
|
8
|
Miano M, Rotulo GA, Palmisani E, Giaimo M, Fioredda F, Pierri F, Pezzulla A, Licciardello M, Terranova P, Lanza T, Cappelli E, Maggiore R, Calvillo M, Micalizzi C, Russo G, Dufour C. Sirolimus as a rescue therapy in children with immune thrombocytopenia refractory to mycophenolate mofetil. Am J Hematol 2018; 93:E175-E177. [PMID: 29675829 DOI: 10.1002/ajh.25119] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2018] [Revised: 04/13/2018] [Accepted: 04/17/2018] [Indexed: 01/17/2023]
Affiliation(s)
- Maurizio Miano
- Hematology Unit, IRCCS Istituto Giannina Gaslini; Genoa Italy
| | | | - Elena Palmisani
- Hematology Unit, IRCCS Istituto Giannina Gaslini; Genoa Italy
| | | | | | - Filomena Pierri
- Hematology Unit, IRCCS Istituto Giannina Gaslini; Genoa Italy
| | - Agnese Pezzulla
- Haematology/Oncology Unit, Dept of Pediatrics; University of Catania- Catania; Italy
| | - Maria Licciardello
- Haematology/Oncology Unit, Dept of Pediatrics; University of Catania- Catania; Italy
| | - Paola Terranova
- Hematology Unit, IRCCS Istituto Giannina Gaslini; Genoa Italy
| | - Tiziana Lanza
- Hematology Unit, IRCCS Istituto Giannina Gaslini; Genoa Italy
| | - Enrico Cappelli
- Hematology Unit, IRCCS Istituto Giannina Gaslini; Genoa Italy
| | | | | | | | - Giovanna Russo
- Haematology/Oncology Unit, Dept of Pediatrics; University of Catania- Catania; Italy
| | - Carlo Dufour
- Hematology Unit, IRCCS Istituto Giannina Gaslini; Genoa Italy
| |
Collapse
|
9
|
Palmisani E, Miano M, Micalizzi C, Calvillo M, Pierri F, Terranova P, Lanza T, Lanciotti M, Riccardi F, Todiere A, Zanardi S, Caviglia I, Dufour C, Fioredda F. Clinical features and therapeutic challenges of cytopenias belonging to alps and alps-related (ARS) phenotype. Br J Haematol 2018. [PMID: 29527658 DOI: 10.1111/bjh.15178] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Affiliation(s)
- Elena Palmisani
- Haematology Unit, IRCCS-Istituto Giannina Gaslini, Genoa, Italy
| | - Maurizio Miano
- Haematology Unit, IRCCS-Istituto Giannina Gaslini, Genoa, Italy
| | | | | | - Filomena Pierri
- Haematology Unit, IRCCS-Istituto Giannina Gaslini, Genoa, Italy
| | - Paola Terranova
- Haematology Unit, IRCCS-Istituto Giannina Gaslini, Genoa, Italy
| | - Tiziana Lanza
- Haematology Unit, IRCCS-Istituto Giannina Gaslini, Genoa, Italy
| | | | | | - Andrea Todiere
- Haematology Unit, IRCCS-Istituto Giannina Gaslini, Genoa, Italy
| | - Sabrina Zanardi
- Epidemiology and Biostatistics Unit, IRCCS-Istituto Giannina Gaslini, Genoa, Italy
| | - Ilaria Caviglia
- Infectious Disease Unit, IRCCS-Istituto Giannina Gaslini, Genoa, Italy
| | - Carlo Dufour
- Haematology Unit, IRCCS-Istituto Giannina Gaslini, Genoa, Italy
| | | |
Collapse
|
10
|
Bicocchi M, Lanza T, Bottini F, Molinari A, Rosano C, Acquila M, Pasino M. Ectopic mRNA analysis and molecular modelling substantiate severe haemophilia in a patient with a FVIII gene splice mutation. Thromb Haemost 2017. [DOI: 10.1055/s-0037-1616251] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
11
|
Farruggia P, Puccio G, Fioredda F, Lanza T, Porretti L, Ramenghi U, Barone A, Bonanomi S, Finocchi A, Ghilardi R, Ladogana S, Marra N, Martire B, Notarangelo LD, Onofrillo D, Pillon M, Russo G, Lo Valvo L, Serafinelli J, Tucci F, Zunica F, Verzegnassi F, Dufour C. Autoimmune neutropenia of childhood secondary to other autoimmune disorders: Data from the Italian neutropenia registry. Am J Hematol 2017; 92:E546-E549. [PMID: 28567966 DOI: 10.1002/ajh.24803] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2017] [Accepted: 05/26/2017] [Indexed: 11/07/2022]
Affiliation(s)
- Piero Farruggia
- Pediatric Hematology and Oncology Unit, A.R.N.A.S. Ospedale Civico, Palermo, Italy
| | - Giuseppe Puccio
- Department of Sciences for Health Promotion, University of Palermo, Italy
| | - Francesca Fioredda
- Clinical and Experimental Hematology Unit, G. Gaslini Children's Hospital, Genova, Italy
| | - Tiziana Lanza
- Clinical and Experimental Hematology Unit, G. Gaslini Children's Hospital, Genova, Italy
| | - Laura Porretti
- Flow Cytometry Service, Laboratory of Clinical Chemistry and Microbiology, IRCCS "Ca' Granda" Foundation, Maggiore Hospital Policlinico, Milan, Italy
| | - Ugo Ramenghi
- Ematologia, Dipartimento di Scienze Pediatriche, Ospedale Infantile Regina Margherita, Torino, Italy
| | - Angelica Barone
- Department of Pediatric Onco-hematology, University Hospital, Parma, Italy
| | - Sonia Bonanomi
- Fondazione MBBM, Clinica Pediatrica, Università di Milano - Bicocca, A.O. San Gerardo, Monza, Italy
| | | | - Roberta Ghilardi
- Department of Pediatrics, IRCCS "Ca' Granda" Foundation, Maggiore Hospital Policlinico, Milan, Italy
| | - Saverio Ladogana
- Department of Hematology, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
| | | | - Baldassare Martire
- Dipartimento di Scienze e Chirurgia Pediatriche, U. O. Oncoematologia Pediatrica, Ospedale Policlinico- Giovanni XXIII, Bari, Italy
| | - Lucia Dora Notarangelo
- Pediatric Oncology-Hematology and BMT Unit, Children's Hospital, Spedali Civili, Brescia, Italy
| | | | - Marta Pillon
- Dipartimento di Oncoematologia Pediatrica, Università di Padova, Italy
| | - Giovanna Russo
- Pediatric Hematology and Oncology Unit, Policlinico Hospital, University of Catania, Italy
| | - Laura Lo Valvo
- Pediatric Hematology and Oncology Unit, Policlinico Hospital, University of Catania, Italy
| | | | - Fabio Tucci
- Department of Pediatric Onco-Hematology, Meyer Children's Hospital, Florence, Italy
| | - Fiammetta Zunica
- Pediatric Oncology-Hematology and BMT Unit, Children's Hospital, Spedali Civili, Brescia, Italy
| | | | - Carlo Dufour
- Clinical and Experimental Hematology Unit, G. Gaslini Children's Hospital, Genova, Italy
| |
Collapse
|
12
|
Farruggia P, Fioredda F, Puccio G, Porretti L, Lanza T, Ramenghi U, Ferro F, Macaluso A, Barone A, Bonanomi S, Caruso S, Casazza G, Davitto M, Ghilardi R, Ladogana S, Mandaglio R, Marra N, Martire B, Mastrodicasa E, Dora Notarangelo L, Onofrillo D, Robustelli G, Russo G, Trizzino A, Tucci F, Pillon M, Dufour C. Autoimmune neutropenia of infancy: Data from the Italian neutropenia registry. Am J Hematol 2015; 90:E221-2. [PMID: 26361081 DOI: 10.1002/ajh.24187] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2015] [Accepted: 09/09/2015] [Indexed: 11/11/2022]
Affiliation(s)
- Piero Farruggia
- Pediatric Hematology and Oncology Unit; A.R.N.A.S. Ospedale Civico; Palermo Italy
| | - Francesca Fioredda
- Clinical and Experimental Hematology Unit; G. Gaslini Children's Hospital; Genova Italy
| | - Giuseppe Puccio
- Department of Sciences for Health Promotion; University of Palermo; Palermo Italy
| | - Laura Porretti
- Flow Cytometry Service, Laboratory of Clinical Chemistry and Microbiology; IRCCS “Ca' Granda” Foundation, Maggiore Hospital Policlinico; Milan Italy
| | - Tiziana Lanza
- Clinical and Experimental Hematology Unit; G. Gaslini Children's Hospital; Genova Italy
| | - Ugo Ramenghi
- Ematologia del Dipartimento Di Scienze Pediatriche; Ospedale Infantile Regina Margherita; Torino Italy
| | - Francesca Ferro
- Ematologia del Dipartimento Di Scienze Pediatriche; Ospedale Infantile Regina Margherita; Torino Italy
| | - Alessandra Macaluso
- Pediatric Hematology and Oncology Unit; A.R.N.A.S. Ospedale Civico; Palermo Italy
| | - Angelica Barone
- Department of Pediatric Onco-Hematology; University Hospital; Parma Italy
| | - Sonia Bonanomi
- Fondazione MBBM, Clinica Pediatrica; Università Di Milano - Bicocca; Monza Italy
| | - Silvia Caruso
- Servizio Di Epidemiologia E Biostatistica-Istituto; G. Gaslini Children's Hospital; Genova Italy
| | - Gabriella Casazza
- Paediatric Hematology Oncology, Bone Marrow Transplant; Azienda Ospedaliero Universitaria Pisana, Ospedale S. Chiara; Pisa Italy
| | - Mirella Davitto
- Ematologia del Dipartimento Di Scienze Pediatriche; Ospedale Infantile Regina Margherita; Torino Italy
| | - Roberta Ghilardi
- Department of Pediatrics; IRCCS “Ca' Granda” Foundation, Maggiore Hospital Policlinico; Milan Italy
| | - Saverio Ladogana
- Department of Hematology; IRCCS Casa Sollievo Della Sofferenza; San Giovanni Rotondo Italy
| | | | | | - Baldassare Martire
- Dipartimento Di Scienze E Chirurgia Pediatriche; U. O. Oncoematologia Pediatrica, Ospedale Policlinico- Giovanni XXIII; Bari Italy
| | - Elena Mastrodicasa
- Pediatric Oncology Hematology Unit; S. Maria Della Misericordia Hospital; Perugia Italy
| | - Lucia Dora Notarangelo
- Pediatric Oncology-Hematology and BMT Unit; Children’ Hospital, Spedali Civili; Brescia Italy
| | | | - Giuseppe Robustelli
- Fondazione MBBM, Clinica Pediatrica; Università Di Milano - Bicocca; Monza Italy
| | - Giovanna Russo
- Pediatric Hematology and Oncology Unit; Policlinico Hospital, University of Catania; Catania Italy
| | - Angela Trizzino
- Pediatric Hematology and Oncology Unit; A.R.N.A.S. Ospedale Civico; Palermo Italy
| | - Fabio Tucci
- Department of Pediatric Oncology-Hematology; Meyer Children's Hospital; Florence Italy
| | - Marta Pillon
- Dipartimento Di Oncoematologia Pediatrica; Università Di Padova; Padova Italy
| | - Carlo Dufour
- Clinical and Experimental Hematology Unit; G. Gaslini Children's Hospital; Genova Italy
| |
Collapse
|
13
|
Miano M, Scalzone M, Perri K, Palmisani E, Caviglia I, Micalizzi C, Svahn J, Calvillo M, Banov L, Terranova P, Lanza T, Dufour C, Fioredda F. Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience. Br J Haematol 2015; 171:247-253. [PMID: 26058843 DOI: 10.1111/bjh.13533] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2015] [Accepted: 04/30/2015] [Indexed: 01/19/2023]
Abstract
The management of refractory autoimmune cytopenias in childhood is challenging due to the lack of established evidence on escalating treatments. The long-term efficacy of immunosuppressive drugs was evaluated in children with refractory autoimmune cytopenias referred to the Haematology Unit of the Gaslini Children's Hospital between 2001 and 2014. Patients were grouped into three categories: autoimmune lymphoproliferative syndrome (ALPS), ALPS-related syndrome (at least one absolute/primary additional criterion for ALPS) and primary autoimmune cytopenia (PAC, cytopenia with no other immunological symptoms/signs). Fifty-eight children (aged 1-16 years) entered the study: 12 were categorized with ALPS, 24 were ALPS-related and 22 had PAC. Five didn't receive treatment. Fifty-three were initially treated with steroids/intravenous immunoglobulin. Fourteen responded, whereas 39 did not. Of these 39 patients, 34 (87%) received mycophenolate mofetil (MMF) as second/further-line treatment and 22 (65%) responded. Within these 34 subjects, ALPS patients responded better (11/11, 100%) than the two other groups pooled together (11/23, 48%; P = 0·002). Sirolimus was given as second/further-line treatment to 16 children, and 12 (75%) responded, including 8 who previously failed MMF therapy. Median follow-up was 3·46 years. MMF and Sirolimus were well-tolerated and enabled partial/complete and sustained remission in most children. These drugs may be successfully and safely used in children with refractory autoimmune cytopenias with or without ALPS/ALPS-related disorders and may represent a valid second/further line option.
Collapse
Affiliation(s)
- Maurizio Miano
- Clinical and Experimental Haematology Unit, Giannina Gaslini Children's Hospital, Genova, Italy
| | - Maria Scalzone
- Clinical and Experimental Haematology Unit, Giannina Gaslini Children's Hospital, Genova, Italy
| | - Katia Perri
- Clinical and Experimental Haematology Unit, Giannina Gaslini Children's Hospital, Genova, Italy
| | - Elena Palmisani
- Clinical and Experimental Haematology Unit, Giannina Gaslini Children's Hospital, Genova, Italy
| | - Ilaria Caviglia
- Infectious Disease Unit, Giannina Gaslini Children's Hospital, Genova, Italy
| | - Concetta Micalizzi
- Clinical and Experimental Haematology Unit, Giannina Gaslini Children's Hospital, Genova, Italy
| | - Johanna Svahn
- Clinical and Experimental Haematology Unit, Giannina Gaslini Children's Hospital, Genova, Italy
| | - Michaela Calvillo
- Clinical and Experimental Haematology Unit, Giannina Gaslini Children's Hospital, Genova, Italy
| | - Laura Banov
- Clinical and Experimental Haematology Unit, Giannina Gaslini Children's Hospital, Genova, Italy
| | - Paola Terranova
- Clinical and Experimental Haematology Unit, Giannina Gaslini Children's Hospital, Genova, Italy
| | - Tiziana Lanza
- Clinical and Experimental Haematology Unit, Giannina Gaslini Children's Hospital, Genova, Italy
| | - Carlo Dufour
- Clinical and Experimental Haematology Unit, Giannina Gaslini Children's Hospital, Genova, Italy
| | - Francesca Fioredda
- Clinical and Experimental Haematology Unit, Giannina Gaslini Children's Hospital, Genova, Italy
| |
Collapse
|
14
|
Svahn J, Lanza T, Rathbun K, Bagby G, Ravera S, Corsolini F, Pistorio A, Longoni D, Farruggia P, Dufour C, Cappelli E. p38 Mitogen-activated protein kinase inhibition enhances in vitro erythropoiesis of Fanconi anemia, complementation group A-deficient bone marrow cells. Exp Hematol 2014; 43:295-9. [PMID: 25534205 DOI: 10.1016/j.exphem.2014.11.010] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2014] [Accepted: 11/25/2014] [Indexed: 11/17/2022]
Abstract
Bone marrow failure in Fanconi anemia (FA) has been linked in part to overproduction of inflammatory cytokines, to which FA stem and progenitor cells are hypersensitive. In cell lines and murine models p38 mitogen-activated protein kinase (MAPK)-dependent tumor necrosis factor α (TNF-α) overexpression can be induced by the Toll-like receptors (TLRs) 4 and 7/8 ligands Lipopolysaccharide (LPS) and R848. Ex vivo exposure of FA stem cells to TNF-α suppresses their replication and selects preleukemic clones. Here we show that inhibition of p38 MAPK also reduces TLR4 and 7/8-mediated TNF-α production in primary human FA complementation group A (FANCA)-deficient monocytes from nine patients and demonstrate that, while p38 MAPK inhibition also enhances clonal growth of FANCA-deficient erythroid progenitors, the effect was mediated indirectly by the influence of the inhibitor on auxiliary cells, not erythroid colony-forming units themselves. Taken together, these results support the view that inhibition of the p38 MAPK pathway in monocytes may improve hematopoiesis in FANCA patients.
Collapse
Affiliation(s)
- Johanna Svahn
- Hematology Unit, Istituto Giannina Gaslini, Genoa, Italy
| | - Tiziana Lanza
- Hematology Unit, Istituto Giannina Gaslini, Genoa, Italy
| | - Keaney Rathbun
- Oregon Health & Science University, Portland, OR, United States
| | - Grover Bagby
- Oregon Health & Science University, Portland, OR, United States
| | - Silvia Ravera
- DIFAR-Biochemistry Laboratory, Department of Pharmacology, University of Genoa, Genoa, Italy
| | - Fabio Corsolini
- Laboratorio Diagnosi Pre e Postnatale Malattie Metaboliche, Istituto Giannina Gaslini, Genoa, Italy
| | - Angela Pistorio
- Epidemiology and Biostatistics Unit, Istituto Giannina Gaslini, Genoa, Italy
| | | | - Piero Farruggia
- Pediatric Hematology and Oncology Unit, A.R.N.A.S. Ospedali Civico, Di Cristina e Benfratelli, Palermo, Italy
| | - Carlo Dufour
- Hematology Unit, Istituto Giannina Gaslini, Genoa, Italy
| | | |
Collapse
|
15
|
Miano M, Calvillo M, Palmisani E, Fioredda F, Micalizzi C, Svahn J, Banov L, Russo G, Lanza T, Dufour C. Sirolimus for the treatment of multi-resistant autoimmune haemolytic anaemia in children. Br J Haematol 2014; 167:571-4. [DOI: 10.1111/bjh.13010] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Affiliation(s)
- Maurizio Miano
- Haematology Unit; G. Gaslini Children's Hospital; Genoa Italy
| | | | - Elena Palmisani
- Haematology Unit; G. Gaslini Children's Hospital; Genoa Italy
| | | | | | - Johanna Svahn
- Haematology Unit; G. Gaslini Children's Hospital; Genoa Italy
| | - Laura Banov
- Haematology Unit; G. Gaslini Children's Hospital; Genoa Italy
| | - Giovanna Russo
- Paediatric Haematology/Oncology Unit; University of Catania; Catania Italy
| | - Tiziana Lanza
- Haematology Unit; G. Gaslini Children's Hospital; Genoa Italy
| | - Carlo Dufour
- Haematology Unit; G. Gaslini Children's Hospital; Genoa Italy
| |
Collapse
|
16
|
Mehta PA, Svahn J, Davies SM, Pang Q, Harris R, Ghezzi P, Lanza T, Ferretti E, Barabino P, Mueller R, Dufour C. Etanercept treatment in Fanconi anaemia; combined US and Italian experience. Br J Haematol 2012; 158:809-11. [PMID: 22834913 DOI: 10.1111/j.1365-2141.2012.09250.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Mattivi F, Caputi L, Carlin S, Lanza T, Minozzi M, Nanni D, Valenti L, Vrhovsek U. Effective analysis of rotundone at below-threshold levels in red and white wines using solid-phase microextraction gas chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2011; 25:483-488. [PMID: 21259356 DOI: 10.1002/rcm.4881] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Rotundone is an oxygenated sesquiterpene belonging to the family of guaianes, giving the 'peppery' aroma to white and black pepper and to red wines. Here we describe a novel, convenient protocol for the synthesis of rotundone, starting from a commercially available compound and requiring only two reaction steps, and an improved, faster method of GC separation (30 min) with selective quantisation of rotundone using tandem mass spectrometry in multiple reaction monitoring (MRM) mode with d(5)-rotundone as internal standard. With limits of detection (LODs) of 1.5 ng/L in white wine and 2.0 ng/L in red wine, intraday repeatability CV values of 6% and 5% at 50 ng/L and 500 ng/L and interday repeatability CV values of 13% and 6% at 50 ng/L and 500 ng/L, respectively, the improved protocol provides the desired sensitivity and selectivity for routine analysis of rotundone in both white and red wines. Initial application of this method highlighted the presence of unexpectedly high concentrations of rotundone, thus explaining the origin of the distinctive peppery aroma in Schioppettino and Vespolina red wines and in Gruener Veltliner white wines.
Collapse
Affiliation(s)
- F Mattivi
- IASMA Research and Innovation Centre, Fondazione Edmund Mach, Via E. Mach 1, 38010 S. Michele all'Adige (TN), Italy.
| | | | | | | | | | | | | | | |
Collapse
|
18
|
Fioredda F, Calvillo M, Lanciotti M, Lanza T, Giunti L, Castagnola E, Lorenzi I, Tonelli R, Ghezzi P, Dufour C. Pegfilgrastim in children with severe congenital neutropenia. Pediatr Blood Cancer 2010; 54:465-7. [PMID: 19927291 DOI: 10.1002/pbc.22350] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Two pediatric patients affected by severe congenital neutropenia (SCN) were treated with 100 mcg/L/dose every 9-12 days within a pilot study (Observatory of the Italian Ministry of Health, Eudract Code 2005-003096-20) on the use of pegfilgrastim in patients with chronic neutropenia. Both children increased their absolute neutrophil count, reduced their infectious load, and improved their quality of life. Serum concentrations of G-CSF observed in pegfilgrastim mirrored those seen in filgrastim. These data suggest that pegfilgrastim may be beneficial in SCN patients with an exposure of hematopoietic cells to G-CSF similar to that on filgrastim.
Collapse
|
19
|
Lanciotti M, Caridi G, Rosano C, Pigullo S, Lanza T, Dufour C. Severe congenital neutropenia: a negative synergistic effect of multiple mutations of ELANE (ELA2) gene. Br J Haematol 2009; 146:578-80. [PMID: 19594744 DOI: 10.1111/j.1365-2141.2009.07787.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
20
|
Dufour C, Giacchino R, Ghezzi P, Tonelli R, Ferretti E, Pitto A, Pistoia V, Lanza T, Svahn J. Etanercept as a salvage treatment for refractory aplastic anemia. Pediatr Blood Cancer 2009; 52:522-5. [PMID: 19061218 DOI: 10.1002/pbc.21886] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
About 10-15% of patients with acquired aplastic anemia (AAA) have resistant/recurrent disease not eligible for standard treatment like hematopoietic stem cell transplantation and/or combined immunosuppression. We report a 17-year-old male with an 11 years history of AAA who, after two courses of immunosuppression, was red cell transfusion-dependent, severely thrombocytopenic, refractory to platelet transfusion, had iron overload and post-transfusion HCV infection. This patient achieved transfusion independence from platelets and normalized Hb after treatment with the anti-TNF agent Etanercept. Over a 12 months follow-up he experienced only transient increase of liver transaminases.
Collapse
Affiliation(s)
- Carlo Dufour
- Haematology Unit, G.Gaslini Children's Hospital, Genova, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Lanciotti M, Pigullo S, Lanza T, Dufour C, Caviglia I, Castagnola E. Possible role of toll-like receptor 9 polymorphism in chemotherapy-related invasive mold infections in children with hematological malignancies. Pediatr Blood Cancer 2008; 50:944. [PMID: 17894360 DOI: 10.1002/pbc.21367] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
22
|
Bicocchi MP, Pasino M, Rosano C, Molinari AC, Della Valle E, Lanza T, Bottini F, Acquila M. Insight into molecular changes of the FIX protein in a series of Italian patients with haemophilia B. Haemophilia 2006; 12:263-70. [PMID: 16643212 DOI: 10.1111/j.1365-2516.2006.01275.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Deficiency or dysfunction of factor IX FIX leads to haemophilia B (HB), an X-linked, recessive, bleeding disorder. On a molecular basis, HB is due to a heterogeneous spectrum of mutations spread throughout the F9 gene. In several instances, a cause-effect relation has been elucidated, in others predicted possibilities have been offered by crystallography inspection and by software-constructed models of the protein. The aim of this study was to contribute to the understanding of HB molecular pathology. The F9 missense mutations we identified in 21 unrelated Italian HB patients by direct sequencing of the whole F9 coding regions were inspected for the causative effect they provoked on the ensuing transcript, and on the protein structure. Each alteration was studied in order to: (i) characterize the defect on the basis of the nature of the mutation; (ii) identify the predicted defect that is induced in the gene and (iii) speculate about the potential, detrimental effects which upset the protein functionality through an idealized FIX model. The resulting data may further contribute to the comprehension of the mechanisms underlying the disease.
Collapse
Affiliation(s)
- M P Bicocchi
- Department of Haematology and Oncology, Thrombosis and Haemostasis Unit, Giannina Gaslini Institute, Genova, Italy
| | | | | | | | | | | | | | | |
Collapse
|
23
|
Acquila M, Pasino M, Lanza T, Molinari AC, Rosano C, Bicocchi MP. Exon skipping partially restores factor VIII coagulant activity in patients with mild hemophilia A with exon 13 duplication. Haematologica 2005; 90:997-9. [PMID: 15996947] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/03/2023] Open
Abstract
Ectopic mRNA was analyzed by reverse transcriptase polymerase chain reaction (RT-PCR) in patients with duplication of F8 gene exon 13, a mutation which has been demonstrated to be a cause of mild hemophilia A in 32% of Northern Italian subjects. Two different transcripts originate from mutated genomic DNA, due to alternative splice processes. The larger-sized transcript contains both duplicated exons 13, the smaller one contains only one exon 13. The residual FVIII:C activity which accounts for the mild hemophilia A phenotype derives from the latter transcript.
Collapse
|
24
|
Acquila M, Pasino M, Lanza T, Molinari AC, Caprino D, Bottini F, Bicocchi MP. Identification of mutations in exon 14 including five novelties in 13 Italian patients with haemophilia A. Haemophilia 2005; 10:744-6. [PMID: 15569173 DOI: 10.1111/j.1365-2516.2004.01032.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
25
|
Bicocchi MP, Migeon BR, Pasino M, Lanza T, Bottini F, Boeri E, Molinari AC, Corsolini F, Morerio C, Acquila M. Familial nonrandom inactivation linked to the X inactivation centre in heterozygotes manifesting haemophilia A. Eur J Hum Genet 2005; 13:635-40. [PMID: 15741993 DOI: 10.1038/sj.ejhg.5201386] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
A basic tenet of the Lyon hypothesis is that X inactivation occurs randomly with respect to parental origin of the X chromosome. Yet, nonrandom patterns of X inactivation are common - often ascertained in women who manifest recessive X-linked disorders despite being heterozygous for the mutation. Usually, the cause of skewing is cell selection disfavouring one of the cell lineages created by random X inactivation. We have identified a three generation kindred, with three females who have haemophilia A because of extreme skewing of X inactivation. Although they have both normal and mutant factor VIII (FVIII) alleles, only the mutant one is transcribed; and, they share an XIST allele that is never transcribed. The skewing in this case seems to result from an abnormality in the initial choice process, which prevents the chromosome bearing the mutant FVIII allele from being an inactive X.
Collapse
Affiliation(s)
- Maria Patrizia Bicocchi
- Thrombosis and Haemostasis Unit, Department of Haematology and Oncology, Giannina Gaslini Institute, Genova, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Bicocchi MP, Pasino M, Lanza T, Bottini F, Molinari AC, Rosano C, Acquila M. Ectopic mRNA analysis and molecular modelling substantiate severe haemophilia in a patient with a FVIII gene splice mutation. Thromb Haemost 2005; 93:391-2. [PMID: 15711765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
|
27
|
Bicocchi MP, Pasino M, Lanza T, Bottini F, Molinari AC, Caprino D, Rosano C, Acquila M. Small FVIII gene rearrangements in 18 hemophilia A patients: five novel mutations. Am J Hematol 2005; 78:117-22. [PMID: 15682412 DOI: 10.1002/ajh.20234] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Hemophilia A (HA) is a disorder caused by mutations of the FVIII gene, which is located on the tip of the long arm of the X chromosome. In a cohort of 18 unrelated Italian patients affected with HA of varying severity, we performed mutational screening of the gene by denaturing high-performance liquid chromatography (DHPLC) and direct sequencing of abnormal peaks. We identified five novel mutations and 9 previously reported DNA alterations. Two of the 9 previously reported alterations were each common to 3 unrelated patients. Six different mutations were characterized as missense alterations, while 8 were non-missense mutations. Among the new gene alterations, one created a stop codon, one consisted of an out-of frame deletion, and one was a splice-site mutation. The last two were missense alterations. In an attempt to better understand the causative effect of the mutations and the clinical variability of the patients, we investigated the consequences of each missense mutation and visualized the effect of the amino acid change on structural FVIII models.
Collapse
Affiliation(s)
- Maria Patrizia Bicocchi
- Department of Hematology and Oncology, Thrombosis and Hemostasis Unit, Giannina Gaslini Institute, Genova, Italy
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Acquila M, Pasino M, Lanza T, Bottini F, Molinari AC, Bicocchi MP. Duplication of exon 13 causes one third of the cases of mild hemophilia A in northern Italy. Haematologica 2004; 89:758-9. [PMID: 15194549] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/29/2023] Open
Abstract
A rearrangement of exon 13 in the factor VIII gene has been identified as the causative mutation in 32% of Northern Italian patients with mild hemophilia A. We have demonstrated that all share a common haplotype, thus suggesting that the mutation likely occurred in a single ancestor. To date, no predominant mutation has been identified in mild hemophilia A, therefore it would be extremely useful to carry out more extensive studies to ascertain whether the mutation is confined to northern Italy.
Collapse
|
29
|
Abstract
Factor VIII gene inversion of intron 1 has recently been reported to be the mutation responsible for haemophilia A in about 5% of severe cases. In our series of patients, which is made up of 77 Italian cases negative for intron 22 inversion, the mutation was found in three sporadic and in one familial patients, with an overall frequency of 5.2%. The carrier status of the patients' female relatives was assessed by mutation analysis and showed that only two-thirds of cases could be considered truly sporadic. The germ-line origin of the mutation was investigated in the two sporadic families by haplotype analysis on genomic DNA of the patients' maternal grandparents. These studies indicated that both mutation events had occurred in the germ cell lines of the patients' healthy grandfather, suggesting that, as already demonstrated for the inversion of intron 22, the male germ cell line is more susceptible to the intrachromosome recombination which leads to the inversion of intron 1.
Collapse
Affiliation(s)
- M Acquila
- Haemostasis and Haemophilia Laboratory, IV Paediatric Department, G Gaslini Institute, Genova, Italy.
| | | | | | | | | | | | | |
Collapse
|
30
|
Abstract
We describe 18 novel mutations, unreported in the Haemophilia A mutation Databases, that have been identified in a cohort of unrelated, Italian patients affected with haemophilia A (HA). Screening of the factor VIII gene (FVIII) was performed using denaturing high-performance liquid chromatography (DHPLC) and direct sequencing. Eight mutations were characterized as non-missense alterations, and the remaining 10 were missense mutations. Heterozygosity for the identified mutations was observed in the female relatives of patients belonging to eight families with sporadic cases. In an attempt to understand better the causative effect of the mutations and the clinical variability of the patients, missense mutation consequences were investigated for: (1) the nature of the new amino acid; (2) the location of the substituted amino acid within crystallographic and theoretical models; and (3) the degree of conservation of the native residue in factor VIII (FVIII) protein and FVIII-related protein family aligned sequences. These research tools have provided evidence that the mutations we describe involve residues that were conserved, at least in FVIII proteins, in all the species we compared.
Collapse
Affiliation(s)
- Maria P Bicocchi
- Haemostasis and Haemophilia Laboratory, IV Paediatric Department, G. Gaslini Institute, Genova, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Bicocchi MP, Pasino M, Bottini F, Lanza T, Mori PG, Acquila M. Mutation analysis impact on the genetic counseling of sporadic hemophilia B families. Am J Med Genet A 2003; 118A:328-31. [PMID: 12687663 DOI: 10.1002/ajmg.a.20016] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Previous studies have shown that hemophilia B (HB) is the result of several different mutations, mostly single nucleotide substitutions, in the factor IX (FIX) gene. In order to evaluate the impact of mutation analysis on genetic counseling in sporadic and uninformative HB familial pedigrees, we re-analyzed by the conformation sensitive gel electrophoresis (CSGE) technique 14 patients, previously studied by restriction fragment length polymorphisms (RFLPs). A single mutation was present within the FIX gene of each patient: 12 mutations were single base substitutions, 1 was a base insertion, and 1 was a four nucleotide deletion; 4/12 mutations have not been described so far. By identifying the detrimental mutations in affected males, carrier status was correctly diagnosed in all the women we studied; 3/12 de novo events were found in maternal meioses with a 25% mutation rate. Identification of the genetic defect was also successfully applied to three prenatal diagnoses.
Collapse
Affiliation(s)
- Maria Patrizia Bicocchi
- Hemostasis and Hemophilia Laboratory, IV Pediatric Department, G. Gaslini Institute, Genova, Italy.
| | | | | | | | | | | |
Collapse
|
32
|
Acquila M, Pasino M, Lanza T, Bottini F, Boeri E, Bicocchi MP. Frequency of factor VIII intron 1 inversion in a cohort of severe hemophilia A Italian patients. Haematologica 2003; 88:ELT17. [PMID: 12745291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/02/2023] Open
|
33
|
Bicocchi MP, Pasino M, Bottini F, Lanza T, Mori PG, Acquila M. Mutation analysis is an essential strategy in the genetic counselling of sporadic haemophilia B families. Haemophilia 2002; 8:730-2. [PMID: 12199691 DOI: 10.1046/j.1365-2516.2002.00657_2.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
34
|
Hagmann WK, Durette PL, Lanza T, Kevin NJ, de Laszlo SE, Kopka IE, Young D, Magriotis PA, Li B, Lin LS, Yang G, Kamenecka T, Chang LL, Wilson J, MacCoss M, Mills SG, Van Riper G, McCauley E, Egger LA, Kidambi U, Lyons K, Vincent S, Stearns R, Colletti A, Teffera J, Tong S, Fenyk-Melody J, Owens K, Levorse D, Kim P, Schmidt JA, Mumford RA. The discovery of sulfonylated dipeptides as potent VLA-4 antagonists. Bioorg Med Chem Lett 2001; 11:2709-13. [PMID: 11591507 DOI: 10.1016/s0960-894x(01)00544-3] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Directed screening of a carboxylic acid-containing combinatorial library led to the discovery of potent inhibitors of the integrin VLA-4. Subsequent optimization by solid-phase synthesis afforded a series of sulfonylated dipeptide inhibitors with structural components that when combined in a single hybrid molecule gave a sub-nanomolar inhibitor as a lead for medicinal chemistry. Preliminary metabolic studies led to the discovery of substituted biphenyl derivatives with low picomolar activities. SAR and pharmacokinetic characterization of this series are presented.
Collapse
Affiliation(s)
- W K Hagmann
- Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Valetto A, Di Martino D, Scuderi F, Lanza T, Lanciotti M, Bottini F, Dini G. Detection of T cell receptor delta gene rearrangements in childhood B and T lineage acute lymphoblastic leukaemia by southern blot and PCR: technical comparison of two methods of analysis. Clin Lab Haematol 2000; 22:263-9. [PMID: 11122266 DOI: 10.1046/j.1365-2257.2000.00317.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Molecular analysis of antigen receptor genes (Ig and TCR) has been useful for clonal studies in acute lymphoblastic leukaemia (ALL) patients. Rearrangements of these genes can be used to track the persistence of the leukaemic clone during the therapy. The purpose of our study was to analyse the percentage and the pattern of the rearrangements at the TCR D locus in a series of ALL patients, comparing the results obtained by Southern blot and PCR. Genomic DNA was extracted from mononuclear BM cells of 40 paediatric ALL cases, digested with different restriction enzymes and hybridized to TCRDJ1 probe to study the TCR delta locus. Amplification of the rearranged TCR delta genes was performed by PCR to define the gene segments involved. The junctional region was deduced from the sequence to obtain patient-specific primers. Among the 31 B lineage ALL samples, one or two TCR delta alleles proved to be rearranged in 53% of cases. Two different types of rearrangements were chiefly detected: Vdelta2Ddelta3 and Ddelta2Ddelta3. In T-ALL patients, the predominant rearrangement involved the Vdelta1 and the Jdelta1 gene segments.
Collapse
MESH Headings
- Adolescent
- Alleles
- Base Sequence
- Blotting, Southern
- Child
- Child, Preschool
- DNA, Neoplasm/chemistry
- DNA, Neoplasm/genetics
- Female
- Gene Rearrangement, delta-Chain T-Cell Antigen Receptor/genetics
- Humans
- Immunophenotyping
- Infant
- Leukemia-Lymphoma, Adult T-Cell/genetics
- Leukemia-Lymphoma, Adult T-Cell/immunology
- Male
- Molecular Sequence Data
- Polymerase Chain Reaction
- Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics
- Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology
- Receptors, Antigen, T-Cell, gamma-delta/genetics
- Sequence Analysis, DNA
Collapse
Affiliation(s)
- A Valetto
- Division of Paediatric Hematology, G. Gaslini Children's Research Hospital, Genoa, Italy.
| | | | | | | | | | | | | |
Collapse
|
36
|
Pasino M, Lanza T, Marotta F, Scarso L, De Biasio P, Amato S, Corcione A, Pistoia V, Mori PG. Flow cytometric and functional characterization of AC133+ cells from human umbilical cord blood. Br J Haematol 2000; 108:793-800. [PMID: 10792285 DOI: 10.1046/j.1365-2141.2000.01949.x] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
AC133+ cells may represent an alternative source of transplantable haemopoietic progenitor cells to CD34+ cells. Here, we have addressed the characterization of umbilical cord blood (UCB) AC133+ cells and compared their immunophenotypic and functional features with those of UCB CD34+ cells. UCB AC133+ and CD34+ cell fractions were purified by magnetic cell sorting, analysed by flow cytometry, tested for their content in blast cell colony-forming units (CFU-Bl), erythroid and granulocyte-macrophage colony-forming units before and after expansion in the presence of various haemopoietic growth factor combinations. Median AC133+ cell yield was 62.3%, and median AC133+ population purity was 97.9%. AC133+ cells were found to contain significantly more CFU-Bl than CD34+ cells; furthermore, the replating efficiency, i.e. the number of CFU-Bl capable of generating secondary colonies, was higher in the former than in the latter cells. Both AC133+ and CD34+ cells displayed an increased ability to give rise to committed progenitors after 7-day expansion in liquid cultures. These data suggest that the AC133+ cell subset is a heterogeneous pool of immature and more differentiated cells that can be maintained and expanded in well-defined culture conditions. In comparison with CD34+ cells, UCB AC133+ cells appear to contain a higher number of early haemopoietic progenitors.
Collapse
Affiliation(s)
- M Pasino
- Division of Paediatric Haematology and Oncology, Blood Transfusion Bank, Division of Obstetrics, and Laboratory of Oncology, G. Gaslini Institute, Genoa, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Spasari A, Apollini L, Lanza T, Zagordi A, Pirritano D, Falvo F, Scalfari A. Neurologically impaired patients at urologica/ risk: Social-health aspects of the problem in our territory. Urologia 1998. [DOI: 10.1177/039156039806500137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
In view of the lack of spinal units in Calabria and Institutes from which information can be obtained on the conditions of patients with injuries to the spinal cord, we researched such patients (approx. 500,000) with urological risk in our territory. We included in our study 81 patients, 62 men and 19 women, aged between 18 and 78 years. Significant uro-andrological problems were found in 42 patients. It is to be hoped that the survey contributes to improving the poor assistance at present provided for persons with injuries to the spinal cord in Calabria.
Collapse
Affiliation(s)
- A. Spasari
- Divisione Urologica - Azienda Ospedaliera “Pugliese-Ciaccio” - Catanzaro
| | - L. Apollini
- Divisione Urologica - Azienda Ospedaliera “Pugliese-Ciaccio” - Catanzaro
| | - T. Lanza
- Divisione Urologica - Azienda Ospedaliera “Pugliese-Ciaccio” - Catanzaro
| | - A. Zagordi
- Divisione Urologica - Azienda Ospedaliera “Pugliese-Ciaccio” - Catanzaro
| | - D. Pirritano
- Divisione Urologica - Azienda Ospedaliera “Pugliese-Ciaccio” - Catanzaro
| | - F. Falvo
- Divisione Urologica - Azienda Ospedaliera “Pugliese-Ciaccio” - Catanzaro
| | - A. Scalfari
- Divisione Urologica - Azienda Ospedaliera “Pugliese-Ciaccio” - Catanzaro
| |
Collapse
|
38
|
Caione P, Arena F, Biraghi M, Cigna RM, Chendi D, Chiozza ML, De Lisa A, De Grazia E, Fano M, Formica P, Garofalo S, Gramenzi R, von Heland M, Lanza P, Lanza T, Maffei S, Manieri C, Merlini E, Miano L, Nappo S, Pagliarulo A, Paolini Paoletti F, Pau AC, Porru D, Artibani W. Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin. Eur Urol 1997; 31:459-63. [PMID: 9187908 DOI: 10.1159/000474507] [Citation(s) in RCA: 45] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
OBJECTIVE Different etiopathological mechanisms of enuresis are today under study, and different therapies and drugs have been proposed. The Italian Multicentric Trial was undertaken in twelve pediatric and urological centers in order to assess the efficacy of two of the most popular drugs, desmopressin (DDAVP) and oxybutynin. METHODS 114 enuretic patients were enrolled in the study. After a 2-week observation period, 66 patients with primary monosymptomatic enuresis were treated with DDAVP, 30 micrograms/day intranasally, for 6 weeks, 48 patients with enuresis and voiding dysfunction were randomly assigned to a protocol with oxybutynin alone or oxybutynin plus DDAVP. The efficacy of the two drugs was measured in terms of reduction of wet nights per week during the 6-week treatment period and a 2-week follow-up period. Children with 0-3 dry nights/week were considered as nonresponders. RESULTS Patients with monosymptomatic enuresis treated with DDAVP reported a significantly lower number of wet night during treatment than during the baseline period, with 79% showing a 'good' (6-7 dry nights/week) or 'intermediate' response (4-5 dry nights/week). Of the patients with diurnal voiding disturbances and enuresis, those treated with oxybutynin alone had a 54% success rate. The patients treated with both oxybutynin and DDAVP showed a better response, with a 71% rate of success. CONCLUSIONS The efficacy of the two drugs is confirmed in patients carefully selected on the clinical basis of voiding disturbances. In patients with enuresis and voiding dysfunction, the reduced urinary output and the lower bladder filling rate due to DDAVP can reduce uninhibited bladder contractions, thus enhancing the oxybutynin action.
Collapse
Affiliation(s)
- P Caione
- Division of Pediatric Urology, Bambino Gesù' Children's Hospital, Rome, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Pirritano D, Falvo F, Spasari A, De Pasquale M, Talarico B, Lanza T, Ventrice GA, Martino L, Lanza P. Calcolosi vescicale gigante. Urologia 1995. [DOI: 10.1177/039156039506200430] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
The authors report their experience in 10 cases of giant calculosis of the bladder. Their formation secondary to obstructive cervico-urethral pathology is highlighted and treatment of the latter remains of prime importance.
Collapse
Affiliation(s)
- D. Pirritano
- Divisione Urologica - Ospedale Civile “A. Pugliese” - Catanzaro
| | - F. Falvo
- Divisione Urologica - Ospedale Civile “A. Pugliese” - Catanzaro
| | - A. Spasari
- Divisione Urologica - Ospedale Civile “A. Pugliese” - Catanzaro
| | - M. De Pasquale
- Divisione Urologica - Ospedale Civile “A. Pugliese” - Catanzaro
| | - B. Talarico
- Divisione Urologica - Ospedale Civile “A. Pugliese” - Catanzaro
| | - T. Lanza
- Divisione Urologica - Ospedale Civile “A. Pugliese” - Catanzaro
| | - G. A. Ventrice
- Divisione Urologica - Ospedale Civile “A. Pugliese” - Catanzaro
| | - L.F. Martino
- Divisione Urologica - Ospedale Civile “A. Pugliese” - Catanzaro
| | - P. Lanza
- Divisione Urologica - Ospedale Civile “A. Pugliese” - Catanzaro
| |
Collapse
|
40
|
Ventrice G, Martino L, Pirritano D, De Pasquale M, Spasari A, Lanza T, Lanza P, Lavecchia A, Feudale E, Tucci L, Docimo C. Urachal adenocarcinoma: Case report. Urologia 1995. [DOI: 10.1177/039156039506200316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The Authors describe a case of urachal adenocarcinoma. The patient was a 36-year-old man who had already undergone segmentai (cupula) cystectomy at another hospital. The result of the histological test was: urachal adenocarcinoma. Afterwards a C.T. scan was taken which was negative. Then the patient had a cystoscopy with biopsy (negative) in our hospital, and underwent a new segmentai cystectomy releasing the urachus. The result of the second histological test was urachal adenocarcinoma. The Authors underline the rareness of this pathology, and the importance of total or segmentai cystectomy for treatment of the above.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - A. Lavecchia
- Servizio di Anatomia Patologica - Ospedale Civile “A. Pugliese” - Catanzaro
| | - E. Feudale
- Servizio di Anatomia Patologica - Ospedale Civile “A. Pugliese” - Catanzaro
| | - L. Tucci
- Servizio di Anatomia Patologica - Ospedale Civile “A. Pugliese” - Catanzaro
| | - C. Docimo
- Servizio di Anatomia Patologica - Ospedale Civile “A. Pugliese” - Catanzaro
| |
Collapse
|
41
|
Lanza P, Scalfari A, Spasari A, Catuogno C, Falvo F, Talarico B, Lanza T, Gemelli R, De Pasquale M, Pirritano D. Male Pseudohermaphroditism with Persistence of Mullerian Structures: A Particular Case. Urologia 1992. [DOI: 10.1177/039156039205900217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
A case of pseudohermaphroditism with persistence of Mullerian duct derivates in a 77-year-old patient is reported. The patient was phenotypically male and the caryotype was 46 XY. He had a normal penile size and normal sexual function until 3 years previously. The vagina and uterus communicated with the posterior urethra. Laparatomy showed an almost normal uterus with the testicles at the end of the fallopian tubes. Problems concerning embryogenesis and management are discussed.
Collapse
Affiliation(s)
- P. Lanza
- Divisione di Urologia - Ospedale “A. Pugliese” - Catanzaro
| | - A. Scalfari
- Divisione di Urologia - Ospedale “A. Pugliese” - Catanzaro
| | - A. Spasari
- Divisione di Urologia - Ospedale “A. Pugliese” - Catanzaro
| | - C. Catuogno
- Divisione di Urologia - Ospedale “A. Pugliese” - Catanzaro
| | - F. Falvo
- Divisione di Urologia - Ospedale “A. Pugliese” - Catanzaro
| | - B. Talarico
- Divisione di Urologia - Ospedale “A. Pugliese” - Catanzaro
| | - T. Lanza
- Divisione di Urologia - Ospedale “A. Pugliese” - Catanzaro
| | - R. Gemelli
- Divisione di Urologia - Ospedale “A. Pugliese” - Catanzaro
| | - M. De Pasquale
- Divisione di Urologia - Ospedale “A. Pugliese” - Catanzaro
| | - D. Pirritano
- Divisione di Urologia - Ospedale “A. Pugliese” - Catanzaro
| |
Collapse
|
42
|
Franchini E, Lanza T. A rosetting test with papain-treated erythrocytes (RBC) for the detection of a minor erythrocyte population (chimerism) with different antigenic expressivity. Haematologica 1991; 76:334-6. [PMID: 1794741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
A rosetting test with papain-treated erythrocytes was set up and evaluated for the detection of minor erythrocyte populations (chimerism), which can be distinguished by their antigenic differences. The test, for Rh system antigenic differences, has been able to detect erythrocyte populations with a 0.5: 1000 density and a sensitivity 3-4 times as high as that of the antiglobulin test. Critical elements for the optimization of the test are: the final ratio between papain-treated erythrocytes and erythrocytes examined (2:1); the specificity check of the antiserum used which, considering the increased sensitivity, must be performed by the rosetting test itself; the accurate and delicate resuspension of the final pellet. Some disadvantages are the impossibility to detect antigenicity that can be altered by papain and, above all, the scarce possibility of quantifying, if not roughly, the size of the minor population.
Collapse
Affiliation(s)
- E Franchini
- Blood Bank, G. Gaslini Research Children's Hospital, Genova, Italy
| | | |
Collapse
|
43
|
Lanza P, Falvo F, Sparasi A, Lanza T. [Free graft of the peritoneum in surgery of the renal pelvis and ureter]. ARCH ESP UROL 1988; 41:237-9. [PMID: 3401049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
44
|
Mori PG, Lanza T, Mancuso G, De Mattia D, Catera P, Miano C, Del Principe D, Cottafava F. Treatment of acute idiopathic thrombocytopenic purpura (AITP): cooperative Italian study group results. Pediatr Hematol Oncol 1988; 5:169-78. [PMID: 3155240 DOI: 10.3109/08880018809031267] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
A cooperative Italian study group on acute idiopathic thrombocytopenic purpura (AITP) has been designed to evaluate efficacy and safety of no treatment at the onset of the disease and sequential treatment with immunoglobulin and high dose steroid. One hundred thirty-eight patients with AITP entered in the trial. Eleven patients were treated before the end of the waiting period because of bleeding. One hundred twenty-seven (92%) received no treatment for the first 10 days of the disease, 65 patients (51.18%) recovered spontaneously, 62 patients were treated with immunoglobulin, and 52 (83.8%) of them responded positively but only 36 (58.06%) permanently. There was no statistical difference between the results obtained with 400 mg/kg for 5 days versus 200 mg/kg. Twenty-four patients were treated with high doses of steroids, 20 (83.3%) with positive response, and 10 (41.66%) were permanently cured. Four (3.14%) of the patients enrolled in the protocol still had active disease at the end of treatment, and 10 relapsed within 4 months after the end of the treatment.
Collapse
Affiliation(s)
- P G Mori
- Department of Paediatric Haematology and Oncology, G. Gaslini Children's Hospital, Genoa, Italy
| | | | | | | | | | | | | | | |
Collapse
|
45
|
Boeri E, Lanza T, Molinari AC, Barabino A, Pecorara M, Perutelli P, Favareto F, Arigliani R, Mori PG. [Idiopathic chronic thrombocytopenia of childhood treated with immunoglobulins]. Minerva Pediatr 1985; 37:637-8. [PMID: 4079883] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|
46
|
Abstract
The authors report on the use of a patch of peritoneum in the reconstruction of the renal pelvis. Four successful cases are reported. This leads to the use of such a technique in the reconstruction of the pelvis whenever repair by simple apposition of the margins is impossible.
Collapse
|
47
|
|
48
|
Lanza P, Falvo F, Pirritano D, Lanza T. La Sisomicina Nel Trattamento Delle Infezioni Delle Vie Urinarie. Urologia 1983. [DOI: 10.1177/039156038305000312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
49
|
Bonney RJ, Wightman PD, Dahlgren ME, Sadowski SJ, Davies P, Jensen N, Lanza T, Humes JL. Inhibition of the release of prostaglandins, leukotrienes and lysosomal acid hydrolases from macrophages by selective inhibitors of lecithin biosynthesis. Biochem Pharmacol 1983; 32:361-6. [PMID: 6553500 DOI: 10.1016/0006-2952(83)90568-3] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
The release of the inflammatory mediators, prostaglandins (PGs), leukotrienes (LT) and lysosomal acid hydrolases (LAH), by macrophages is stimulated by endocytic stimuli such as zymosan. This process can be interfered with by specific inhibitors of phosphatidylcholine (PC) biosynthesis. The diphenylsulfone dapsone and three analogs selectively inhibited [14C]choline incorporation into PC but had varied effects on inhibition of mediator release by macrophages. Dapsone inhibited the release of PGs, LT and LAH, whereas the three closely related structural analogs inhibited LAH release only, with little or no effect on PG production.
Collapse
|
50
|
Bonacci W, Boeri E, Tonini GP, Lanza T, Bruschettini PL, Mori PG, Serra G. [Antithrombin III in the 1st days of life]. Minerva Pediatr 1982; 34:837-40. [PMID: 7155091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
|